ClariCT.AI

ClariPi Inc.
ClariCT.AI is an AI-powered CT image denoising solution to provide increased image clarity in CT examinations with excessive image noise due to either low dose or large patient. It is trained to work in a vendor-agnostic way, to reduce noise and enhance image quality for low-dose and ultra-low-dose DICOM CT images. ClariCT.AI separates image noise selectively while enhancing underlying structures; thus, providing clarity restored images.
claripi-clarict-ai (1).png
claripi-clarict-ai (2).png
claripi-clarict-ai (3).png
claripi-clarict-ai (4).png
claripi-clarict-ai (5).png
claripi-clarict-ai (1).png
claripi-clarict-ai (2).png
claripi-clarict-ai (3).png
claripi-clarict-ai (4).png
claripi-clarict-ai (5).png
Information source: Vendor
Last updated: July 14, 2024

General Information

General
Product name ClariCT.AI
Company ClariPi Inc.
Subspeciality Neuro, Cardiac, MSK, Chest, Abdomen
Modality CT
Disease targeted N/A
Key-features CT Image denoising for any body part
Suggested use During

Technical Specifications

Data characteristics
Population No restrictions
Input CT, contrast or non-contrast
Input format DICOM
Output Enhanced series with ClariCT.AI tag
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 10 - 60 seconds

Regulatory

Certification
CE
Certified, Class IIa , MDD
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) ClariCT.AI software is intended for denoise processing and enhancement of DICOM images from a CT scanner when higher image quality and/or lower dose acquisitions are desired.

Market

Market presence
On market since 06-2019
Distribution channels Siemens Syngo.Via, Nuance PIN, Blackford, Eureka Clinical AI, deepcOS, CARPL.ai
Countries present (clinical, non-research use) 44
Paying clinical customers (institutes) 45
Research/test users (institutes) 12
Pricing
Pricing model Pay-per-use, Subscription, One-time license fee
Based on Number of installations, Number of analyses

Evidence

Evidence
Peer reviewed papers on performance

  • The Impact of AI on Metal Artifacts in CBCT Oral Cavity Imaging (read)

  • Noise-Optimized CBCT Imaging of Temporomandibular Joints—The Impact of AI on Image Quality (read)

  • Incremental Image Noise Reduction in Coronary CT Angiography Using a Deep Learning-Based Technique with Iterative Reconstruction (read)

  • Effect of a novel denoising technique on image quality and diagnostic accuracy in low-dose CT in patients with suspected appendicitis (read)

  • Image quality of ultralow-dose chest CT using deep learning techniques: potential superiority of vendor-agnostic post-processing over vendor-specific techniques (read)

  • Image quality in liver CT: low-dose deep learning vs standard-dose model-based iterative reconstructions (read)

  • Application of Vendor-Neutral Iterative Reconstruction Technique to Pediatric Abdominal Computed Tomography (read)

  • Incremental Image Noise Reduction in Coronary CT Angiography Using a Deep Learning-Based Technique with Iterative Reconstruction (read)

  • Impact of image denoising on image quality, quantitative parameters and sensitivity of ultra-low-dose volume perfusion CT imaging (read)
Non-peer reviewed papers on performance
Other relevant papers

  • SPIE conference proceedings 2020: Combined low-dose simulation and deep learning for CT denoising: application of ultra-low-dose cardiac CTA (read)